Hostname: page-component-586b7cd67f-rdxmf Total loading time: 0 Render date: 2024-11-26T16:20:38.988Z Has data issue: false hasContentIssue false
  • English
  • Français

Does preoperatively administered parecoxib prevent succinylcholine-associated myalgia? A randomized, placebo-controlled trial

Published online by Cambridge University Press:  27 January 2006

J.-U. Schreiber ,
T. Mencke ,
S. Pradarutti ,
S. Jeblick  and
T. Fuchs-Buder
J.-U. Schreiber
Affiliation:
University Hospital of the Saarland, Department of Anaesthesia and Critical Care Medicine, Homburg, Germany
T. Mencke
Affiliation:
University of Rostock, Department of Anaesthesia and Intensive Care Medicine, Rostock, Germany
S. Pradarutti
Affiliation:
University Hospital of the Saarland, Department of Anaesthesia and Critical Care Medicine, Homburg, Germany
S. Jeblick
Affiliation:
University Hospital of the Saarland, Department of Anaesthesia and Critical Care Medicine, Homburg, Germany
T. Fuchs-Buder
Affiliation:
Centre Hospitalier Universitaire Nancy/Brabois, Département d'Anesthesiologie et de Réanimation, Nancy, France
Get access

Extract

Summary

Background and objective: Data from several studies implicate that pre-treatment with non-selective cyclooxygenase inhibitors such as aspirin or diclofenac may decrease the incidence of postoperative succinycholine-related myalgia. We tested the influence of a preoperatively administered selective cyclooxygenase 2 inhibitor, parecoxib, on postoperative myalgia. Methods: After Ethics Committee approval, 68 patients were randomized into two groups (n = 34 each). Group 1 received parecoxib 40 mg intravenously 3 min before induction of anaesthesia, and Group 2 received saline (in a double-blinded manner). Incidence and severity of myalgia was evaluated systematically with a standardized questionnaire 24, 48 and 72 h after anaesthesia. We also the assessed the number of patients who felt limited in their activity due to myalgia. Results: Seven patients in the parecoxib-treated group complained of myalgia compared with 11 in the control group (not significant). No significant difference in the severity of myalgia or in the limitation of patients activity was found between the groups. Conclusion: Intravenous parecoxib 40 mg, when administered before induction of anaesthesia, did not reduce incidence and severity of postoperative myalgia and did not improve activity in those who suffered from myalgia.

Keywords

NEUROMUSCULAR BLOCKING AGENTS, succinylcholineCYCLOOXYGENASE INHIBITORS, parecoxibCOMPLICATIONS, myalgia
Type
Original Article
Information
European Journal of Anaesthesiology , Volume 23 , Issue 4 , April 2006 , pp. 332 - 337
Copyright
© 2006 European Society of Anaesthesiology

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Miller R. Will succinylcholine ever disappear? Anesth Analg 2004; 98: 1674–1675.Google Scholar
Trepanier CA, Brousseau C, Lacerte L. Myalgia in outpatient surgery: comparison of atracurium and succinylcholine. Can J Anaesth 1988; 35: 255–258.Google Scholar
Schreiber JU, Lysakowski C, Fuchs-Buder T, Tramèr MR. Prevention of succinylcholine-induced fasciculation and myalgia: a meta-analysis of randomized trials. Anesthesiology 2005; 103: 877–884.Google Scholar
Leeson-Payne CG, Nicoll JM, Hobbs GJ. Use of keterolac in the prevention of suxamethonium myalgia. Br J Anaesth 1994; 73: 788–790.Google Scholar
McLoughlin C, Elliott P, McCarthy G, Mirakhur RK. Muscle pains and biochemical changes following suxamethonium administration after six pretreatment regimens. Anaesthesia 1992; 47: 202–206.Google Scholar
Hegi TR, Bombeli T, Seifert B et al. Effect of rofecoxib on platelet aggregation and blood loss in gynaecological and breast surgery compared with diclofenac. Br J Anaesth 2004; 92: 523–531.Google Scholar
Mikat-Stevens M, Sukhani R, Pappas AL, Fluder E, Kleinman B, Stevens RA. Is succinylcholine after pretreatment with d-tubocurarine and lidocaine contraindicated for outpatient anesthesia? Anesth Analg 2000; 91: 312–316.Google Scholar
Laupacis A, Sackett DL, Roberts RS. An assessment of clinically useful measures of the consequences of treatment. New Engl J Med 1988; 318: 1728–1733.Google Scholar
Naguib M, Farag H, Magbagbeola JAO. Effect of pre-treatment with lysine acetyl salicylate on suxamethonium-induced myalgia. Br J Anaesth 1987; 59: 606–610.Google Scholar
Schreiber JU, Mencke T, Biedler A et al. Postoperative myalgia after succinylcholine: no evidence for an inflammatory origin. Anesth Analg 2003; 96: 1640–1644.Google Scholar
Kahraman S, Ercan S, Aypar U, Erdem K. Effect of preoperative i.m. administration of diclofenac on suxamethonium-induced myalgia. Br J Anaesth 1993; 71: 238–241.Google Scholar
Rømsing J, Møiniche S. A systematic review of COX-2 inhibitors compared with traditional NSAIDs, or different COX-2 inhibitors for post-operative pain. Acta Anaesthesiol Scand 2004; 48: 525–546.Google Scholar
Barton SF, Langeland FF, Snabes MC et al. Efficacy and safety of intravenous parecoxib sodium in relieving acute postoperative pain following gynecologic laparotomy surgery. Anesthesiology 2002; 97: 306–314.Google Scholar
Noveck RJ, Laurent A, Kuss M et al. Parecoxib sodium does not impair platelet function in healthy elderly and non-elderly individuals. Two randomised, controlled trials. Clin Drug Invest 2001; 21: 465–476.Google Scholar
Mehlisch DR, Desjardins PJ, Daniels S, Hubbard RC. Single doses of parecoxib sodium intravenously are as effective as ketorolac in reducing pain after oral surgery. J Oral Maxillofac Surg 2003; 61: 1030–1037.Google Scholar
Rasmussen GL, Steckner K, Hogue C, Torri S, Hubbard RC. Intravenous parecoxib sodium for acute pain after orthopedic knee surgery. Am J Orthop 2002; 31: 336–343.Google Scholar
Desjardins PJ, Grossman EH, Kuss ME et al. The injectable cyclooxygenase-2-specific inhibitor parecoxib sodium has analgesic efficacy when administered preoperatively. Anesth Analg 2001; 93: 721–727.Google Scholar
Wong SF, Chung F. Succinylcholine-associated postoperative myalgia. Anaesthesia 2000; 55: 144–152.Google Scholar
Laurence AS. Myalgia and biochemical changes following intermittent suxamethonium administration. Effects of alcuronium, lignocaine, midazolam and suxamethonium pretreatments on serum myoglobin, creatine kinase and myalgia. Anaesthesia 1987; 42: 503–510.Google Scholar
Norman PH, Daley MD, Lindsey RW. Preemptive analgesic effects of ketorolac in ankle fracture surgery. Anesthesiology 2001; 94: 599–603.Google Scholar
Reuben SS, Bhopatkar S, Maciolek H, Joshi W, Sklar J. The preemptive analgesic effect of rofecoxib after ambulatory arthroscopic knee surgery. Anesth Analg 2002; 94: 55–59.Google Scholar
Nussmeier NA, Whelton AA, Brown MT et al. Complications of the COX-2 inhibitors parecoxib and valdecoxib after cardiac surgery. New Engl J Med 2005; 352: 1081–1091.Google Scholar
Looney Y, O'Shea A, O'Dwyer R. Severe bronchospasm after parenteral parecoxib: cyclooxygenase-2 inhibitors: not the answer yet. Anesthesiology 2005; 102: 473–475.Google Scholar